Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
1,114 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00422773 | Safety of Cetuximab and Oxaliplatin/5-FU/FA/Irinotecan in First-Line Treatment of Metastatic Colorectal Cancer | completed | Phase 1 / Phase 2 | 21 | Technische Universität DresdenOTHER | 1 | Feb 27, 2009 | clinicaltrials |
| NCT00415155 | A Study of LY2181308 in Patients With Advanced Hepatocellular Carcinoma | withdrawn | Phase 1 / Phase 2 | 60 | Eli Lilly and CompanyINDUSTRY | 4 | Aug 29, 2008 | clinicaltrials |
| NCT00145743 | Diagnostics and Therapy of Disease-Related Quality of Life of Patients With Breast Cancer | completed | Phase 1 / Phase 2 | 200 | Tumor Center RegensburgOTHER | 1 | Nov 27, 2007 | clinicaltrials |
| NCT00562471 | Safety and Efficacy Study of a Hydrogel, Applied Following Removal of Myomas During Gynecologic Surgery, Administered for the Prevention/Reduction of Postoperative Adhesion Formation | completed | Phase 1 / Phase 2 | 76 | Angiotech PharmaceuticalsINDUSTRY | 3 | Nov 22, 2007 | clinicaltrials |
| NCT00306514 | Safety and Immunogenicity of a Melan-A VLP Vaccine in Advanced Stage Melanoma Patients | completed | Phase 1 / Phase 2 | — | Cytos Biotechnology AGINDUSTRY | 1 | Sep 20, 2007 | clinicaltrials |
| NCT00527631 | Adjuvant Whole Abdominal Intensity Modulated Radiotherapy (IMRT) for High Risk Stage FIGO III Patients With Ovarian Cancer(OVAR-IMRT-01) | unknown | Phase 1 | 8 | Heidelberg UniversityOTHER | 1 | Sep 11, 2007 | clinicaltrials |
| NCT00204607 | Intradermal Vaccination With Stabilized Tumor mRNA - a Clinical Phase I/II Trial in Melanoma Patients | completed | Phase 1 / Phase 2 | 20 | University Hospital TuebingenOTHER | 1 | Apr 19, 2007 | clinicaltrials |
| NCT00460447 | Gemtuzumab Ozogamicin Before Allogeneic Stem Cell Transplantation | unknown | Phase 1 / Phase 2 | 30 | University Hospital Carl Gustav CarusOTHER | 1 | Apr 16, 2007 | clinicaltrials |
| NCT00384553 | Risk Adapted Therapy Optimization for Patients With Relapsed or Refractory Aggressive Non-Hodgkin-Lymphoma | unknown | Phase 1 / Phase 2 | 30 | University of MagdeburgOTHER | 1 | Oct 6, 2006 | clinicaltrials |
| NCT00103545 | Use of ACA 125 in Patients With Ovarian Cancer: Safety and Immune Response | completed | Phase 1 / Phase 2 | 36 | AGO Study GroupOTHER | 1 | Oct 2, 2006 | clinicaltrials |
| NCT00311857 | Safety Study of Cetuximab, Radiotherapy and Temozolomide in Primary Glioblastoma Multiforme(GERT) | unknown | Phase 1 / Phase 2 | 46 | Heidelberg UniversityOTHER | 1 | Sep 8, 2006 | clinicaltrials |
| NCT00108875 | Survivin Peptide Vaccination for Patients With Advanced Melanoma, Pancreatic, Colon and Cervical Cancer | unknown | Phase 1 / Phase 2 | 70 | Julius-Maximilians UniversityOTHER | 1 | Jul 28, 2006 | clinicaltrials |
| NCT00034502 | A Trial of ALIMTA (Pemetrexed) Plus Irinotecan in Patients Who Have Been Previously Treated For Metastatic Colorectal Cancer. | completed | Phase 1 / Phase 2 | — | Eli Lilly and CompanyINDUSTRY | 2 | Jul 19, 2006 | clinicaltrials |
| NCT00041808 | Magnetic-Targeted Doxorubicin in Treating Patients With Cancer Metastatic to the Liver | completed | Phase 1 / Phase 2 | 20 | FeRxINDUSTRY | 2 | Jun 24, 2005 | clinicaltrials |
Data updated 22 days agoSource updated unknownsource: clinicaltrials